China Biotechnology Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Biotechnology
Zai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to Profitability
Zai Lab Ltd (ZLAB) reports impressive revenue growth and improved net loss, with a strategic focus on global pipeline advancements and a robust cash position. Nov 13, 2024
GuruFocus News Biotechnology
WuXi Biologics (Cayman) Inc (WXXWY) Half Year 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges
Despite a flat overall revenue, WuXi Biologics (Cayman) Inc (WXXWY) shows resilience with strong non-COVID growth and strategic project acquisitions. Oct 09, 2024
GuruFocus News Biotechnology
Genscript Biotech Corp (GNNSF) (H1 2024) Earnings Call Highlights: Robust Revenue Growth Amidst Challenges
Genscript Biotech Corp (GNNSF) reports a 43.5% revenue increase, narrowing net losses, and strong performance in Legend, despite ProBio setbacks and geopolitical tensions. Oct 09, 2024
GuruFocus Research Biotechnology
Brii Biosciences Ltd (BRIBF) Q2 2024 Earnings Call Transcript Highlights: Strategic Advances and Financial Prudence
Key financial metrics and strategic initiatives underscore Brii Biosciences Ltd (BRIBF)'s commitment to innovation and operational efficiency. Aug 23, 2024